Arab Pharmaceuticals (ADCI) Key Statistics
25 reported figures for Arab Pharmaceuticals — valuation multiples, the latest fiscal year's income statement, balance-sheet totals, growth rates and technical readings. Figures with no reported value are omitted rather than shown as zero.
Valuation
- Market cap
- EGP 2.83B
- P/E (trailing)
- 13.26
- P/B
- 4.1
- Dividend yield (FY 2025)
- 3.2%
Income (latest fiscal year)
- Revenue
- EGP 1.37B
- Net income
- EGP 264.71M
- EBITDA
- EGP 441.5M
- Free cash flow
- EGP 88M
- Profit margin
- 19.32%
Balance sheet
- Total assets
- EGP 1.53B
- Total debt
- EGP 560.26M
- Book value
- EGP 751.28M
Growth
- Revenue growth
- 22.54%
- Profit growth
- 16.17%
- EPS growth
- 16.81%
Per share
- EPS (fiscal year)
- 19.37
- Book value per share
- 62.61
- Dividend per share
- 8.333
- Return on equity
- 38.62%
- Return on assets
- 18.56%
Technical
- RSI (14)
- 49.8
- 50-day moving average
- EGP 277.28
- 200-day moving average
- EGP 220.57
- Beta (1Y)
- 0.44
Shares
- Shares outstanding
- 12M
Fiscal-year figures are as the company last reported them; technical readings refresh with market data.